HEERLEN, NETHERLANDS--(Marketwired - Apr 8, 2013) -
Royal DSM, the global Life Sciences and Materials Sciences company,
announces
today that it has signed a Memorandum of Understanding (MOU) for a
strategic
partnership with Rostekhnologii (Rostec), a Russian State Corporation, in
the
fields of biotechnology and functional materials. The MOU was signed today
in
Amsterdam (Netherlands) in the presence of President Vladimir Putin of the
Russian Federation and Prime Minister Mark Rutte of the Netherlands.
Under the terms of the MOU, DSM and Rostec will explore a potential
cooperation
in the field of conversion of cellulosic biomass from forestry and
agriculture
to fermentable sugars for the production of biofuels and/or biobased
chemicals
as well as the manufacturing of bio-based products such as bioethanol,
biogas
and organic acids from sugars derived from cellulosic biomass.
DSM and Rostec will also explore to cooperate in the area of enhancing the
performance of Russia's fast expanding optical fiber networks using DSM's
UV-
curable resins optical fiber materials. In addition, DSM Dyneema and RT-
Chemcomposite, part of Rostec, will investigate the establishment of a
joint
venture for the production and sales of Uni-Directional products based on
Ultra
High Molecular Weight PE-fibers in Russia using DSM's proprietary
technology for
life protection applications.
Vladimir Artyakov, Deputy CEO of Rostekhnologii, said: "The cooperation
with DSM
will accelerate the process of introducing new, unique products in the
Russian
market to be used in different areas, including biotechnology and
functional
materials. The partnership with DSM is strategic and intended for the long
term."
Feike Sijbesma, Chief Executive Officer and Chairman of the DSM Managing
Board,
said: "As 2013 was declared a year of friendship between the Netherlands
and
Russia, this is a perfect occasion to explore opportunities for further
cooperation between DSM and Russia. With two joint ventures already in
place, I
am looking forward to a successful cooperation in several important
business
areas including the development of advanced biofuels with Rostec."
For DSM, Russia is one of the High Growth Economies the company is focusing
on
in executing its strategy DSM in motion: driving focused growth. DSM's main
business areas in Russia are food and feed ingredients, pharmaceutical
intermediate products, biotechnology, fiber materials, resins and
engineering
plastics. Through its business activities, DSM meets the needs and trends
in the
Russian Federation, including localization (import substitution),
modernization
in technologies and diversification (less oil dependence). In 2012, DSM
celebrated 20 years of presence in Russia.
In 2010 DSM started a joint venture in Tatarstan to contribute to Russia's
goal
of reaching a higher self-sufficiency in animal protein production and
supply by
securing better animal nutrition. In 2011 DSM entered into a long-term
partnership in the area of engineering plastics with JSC KuibyshevAzot in
Tolyatti (Samara Region) in order to supply locally produced products to
the
automotive and electrical & electronics industries.
Rostec
State Corporation Russian Technologies (Rostec) is a Russian corporation
established in 2007 in order to facilitate the development, manufacturing
and
export of high-technology industrial products. Today it comprises about 663
companies with activities ranging from automotive to aviation, building,
electronics, telecommunications and defense technology. Rostec's
subsidiaries
are located in 60 regions of the Russian Federation and supply their
products to
over 70 countries worldwide. In 2012 net sales amounted to RUB 963 billion
(~EUR
24 billion) with more than 900,000 employees.
DSM - Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and
Materials
Sciences DSM is driving economic prosperity, environmental progress and
social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in
global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials.
DSM's
23,500 employees deliver annual net sales of around EUR9 billion. The
company is
listed on NYSE Euronext. More information can be found at www.dsm.com.
Press release-pdf: http://hugin.info/130663/R/1691212/555338.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1691212]
For more information:
DSM Corporate Communications
Herman Betten
tel. +31 (0) 45 5782017
e-mail Email Contact
DSM Investor Relations
Dave Huizing
tel. +31 (0) 45 5782864
e-mail Email Contact
Rostec
Antonina Gribanova
Tel. +7 (967) 053 85 68
e-mail Email Contact
Rostec
Yulia Lebedinskaya
Tel. +7 (967) 053 72 15
e-mail Email Contact
View More
View More
